| 发明名称 |
SUSTAINED-RELEASE FORMULATION OF ROTIGOTINE |
| 摘要 |
Provided herein are methods and compositions for producing formulations systemic delivery of dopamine agonists via the oral inhalation route. Specifically, provided herein are methods and compositions for a formulation of rotigotine that is suitable for administration via oral inhalation. Such methods and compositions are useful in the treatment or amelioration of one or more Parkinson's disease symptom(s). |
| 申请公布号 |
US2014377365(A1) |
申请公布日期 |
2014.12.25 |
| 申请号 |
US201414308007 |
申请日期 |
2014.06.18 |
| 申请人 |
MAP Pharmaceuticals, Inc. |
发明人 |
WU Libo;WATANABE Wiwik |
| 分类号 |
A61K9/16;A61K9/00;A61K31/381 |
主分类号 |
A61K9/16 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A pharmaceutical formulation comprising a dopamine agonist, wherein the pharmaceutical formulation is suitable for administration by oral inhalation. |
| 地址 |
Irvine CA US |
